Abstracts

CIO 2023-33 Tumor Size and Watershed Area Correlates in Progression of Hepatocellular Carcinoma after Segmental Radioembolization

Purpose: To identify factors of incomplete treatment after segmental transarterial radioembolization (TARE) for treatment-naïve and solitary hepatocellular carcinoma (HCC)

Osman Ahmed , MD;

Qian Yu , MD;

Mikin Patel , MD;

Thuong Van Ha , MD;

Anjana Pillai , MD;

Monika Neale , DO, PGY-1;

Ethan Ungchusri , MD;

Natalie Rothenberger , MD;

Rakesh Navuluri , MD;

11/02/2023

CIO 2023-32 Transradial versus Transfemoral Access for Interventional Oncology Procedures: A Systematic Review and Meta-Analysis

Purpose: The procedural and clinical outcomes of a transradial approach (TRA) versus a transfemoral approach (TFA) for interventional oncology (IO) procedures remain unclear.

Denes Szekeres , BS ;

Sajal Akkipeddi , BS;

Derrek Schartz , MD;

Ashwani Sharma , MD;

11/02/2023

CIO 2023-26 The Cost of Catheter Dislodgement

Purpose: Long term care of patient's with complicated disease processes often incurs significant financial burden. This burden if often complicated with misuse or failure of medical devic...

11/02/2023

CIO 2023-25 Rare Instance of Uterine Leiomyomatosis Vascular Extension Into the Cavoatrial Junction

Purpose: The purpose of this case study is to investigate the interesting complications that may arise from uterine Leiomyomas. Uterine Leiomyomas are extremely common in the female popul...

11/01/2023

CIO 2023-24 A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields

Purpose: The purpose of this case study is to exhibit the successful treatment of metastatic liposarcoma in an elderly male patient via Pulsed Electric Fields (PEF) monotherapy.

Ryan Bonshock , MD;

11/01/2023

CIO 2023-17 Multimodal Management of CRC Liver Metastases with Hepatectomy and Microwave Ablation

Purpose: Colorectal malignancy ranks as the third most prevalent global cancer, with liver metastases being the most common spread site. Surgery is considered the gold standard treatment ...

Travis Van Meter , MD;

11/01/2023

CIO 2023-16 Treating Hepatic Tumors with Histotripsy: Insights from the THERESA Trial and Literature Review

Purpose: Histotripsy, an emerging advanced technology, offers a non-invasive approach to tumor removal without heat or ionizing radiation. By utilizing ultrasound, it creates small bubble...

Priyali Saxena ;

Faisal Al-Qawasmi ;

11/01/2023

CIO 2023-15 Survival Outcomes for Yttrium-90 Radioembolization to Treat Unresectable Intrahepatic Cholangiocarcinoma

Purpose: Intrahepatic cholangiocarcinoma (ICC) is a progressive disease with a poor prognosis. Surgical resection is curative, but most patients with ICC are ineligible. While systemic th...

Priyali Saxena ;

Faisal Al-Qawasmi ;

11/01/2023

CIO 2023-13 IMbrave050: Phase 3 study of adjuvant atezolizumab + bevacizumab vs surveillance in hepatocellular carcinoma patients

Purpose: The risk of HCC recurrence after liver resection or ablation with curative intent is 70-80% within 5 years, indicating an unmet need for effective adjuvant therapies. Atezolizuma...

Jeong Heo , MD, PhD;

David Hsieh , MD;

Masatoshi Kudo , MD, PhD;

Han Chu Lee , MD, PhD;

Qinshu Lian , PhD;

Shinichiro Nakamura , MD, PhD;

Kazushi Numata , MD;

Shukui Qin , MD, PhD;

Jessica Spahn , PhD;

Won Young Tak , MD, PhD;

Thomas Uguen , MD;

Edward Cha , PhD;

Lu Wang , MD, PhD, MS;

Minshan Chen , MD, PhD;

Xiaoyu Wen , MD, PhD;

Ann-Lii Cheng , MD, PhD;

Chun Wu , PharmD;

Pierce Chow , MBBS, FRCS, PhD;

Adam Yopp , MD;

Stephen Hack , MBChB;

Jian Zhou , MD, PhD;

11/01/2023

CIO 2023-10 Final Results of the GPX Embolic Device Multi-Center Trial for Distal Applications

Purpose: GPX is a novel aqueous-based liquid embolic agent designed for use in durable and pre-operative transcatheter embolization procedures. A prospective, multicenter first-in-human (...

Martin Krauss ;

Ryan O'Hara ;

11/01/2023